Volume 12, Issue 2, Pages (February 2005)

Slides:



Advertisements
Similar presentations
Volume 12, Issue 8, Pages (August 2005)
Advertisements

Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 21, Issue 1, Pages (January 2014)
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
Volume 21, Issue 1, Pages (January 2014)
Volume 21, Issue 12, Pages (December 2013)
Ambiguous Origin: Two Sides of an Ephrin Receptor Tyrosine Kinase
Volume 12, Issue 1, Pages (January 2005)
Volume 21, Issue 3, Pages (March 2014)
Adding Specificity to Artificial Transcription Activators
Volume 25, Issue 8, Pages e4 (August 2017)
Volume 37, Issue 5, Pages (March 2010)
N. Rochel, J.M. Wurtz, A. Mitschler, B. Klaholz, D. Moras 
Volume 14, Issue 11, Pages (November 2007)
Volume 14, Issue 9, Pages (September 2007)
Volume 14, Issue 11, Pages (November 2007)
Synthesis and Target Identification of Hymenialdisine Analogs
Volume 19, Issue 8, Pages (August 2012)
Volume 23, Issue 4, Pages (April 2016)
Volume 20, Issue 3, Pages (March 2013)
Volume 21, Issue 4, Pages (April 2014)
Volume 13, Issue 9, Pages (September 2006)
Redesign of a Dioxygenase in Morphine Biosynthesis
Volume 22, Issue 6, Pages (June 2015)
An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU in α7 Nicotinic Acetylcholine Receptors  Christopher B.
Small Molecule Fluoride Toxicity Agonists
Volume 13, Issue 9, Pages (September 2006)
Small Molecule Fluoride Toxicity Agonists
Volume 18, Issue 10, Pages (October 2011)
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
Volume 21, Issue 5, Pages (May 2014)
Volume 12, Issue 12, Pages (December 2005)
Volume 17, Issue 1, Pages (January 2010)
Volume 16, Issue 2, Pages (February 2009)
Volume 15, Issue 7, Pages (July 2008)
Volume 14, Issue 11, Pages (November 2007)
Covalent Protein Labeling at Glutamic Acids
Volume 19, Issue 8, Pages (August 2012)
Volume 15, Issue 4, Pages (April 2008)
Volume 17, Issue 11, Pages (November 2010)
Volume 12, Issue 12, Pages (December 2005)
Volume 18, Issue 11, Pages (November 2011)
Volume 12, Issue 1, Pages (January 2005)
Volume 25, Issue 8, Pages e4 (August 2017)
Volume 18, Issue 4, Pages (April 2011)
Volume 20, Issue 2, Pages (February 2013)
Volume 19, Issue 9, Pages (September 2012)
Structural Basis of m7GpppG Binding to Poly(A)-Specific Ribonuclease
Volume 22, Issue 6, Pages (June 2015)
Direct Activation of Epac by Sulfonylurea Is Isoform Selective
Volume 15, Issue 8, Pages (August 2008)
Volume 22, Issue 11, Pages (November 2015)
Volume 24, Issue 12, Pages e11 (December 2017)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Volume 17, Issue 10, Pages (October 2010)
L-DOPA Ropes in tRNAPhe
Richard D. Perrins, Giuseppe Cecere, Ian Paterson, Gerard Marriott 
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Structural Basis of Swinholide A Binding to Actin
David Rodríguez, José Brea, María Isabel Loza, Jens Carlsson  Structure 
Geetanjali J. Jog, Jun Igarashi, Hiroaki Suga  Chemistry & Biology 
Volume 21, Issue 9, Pages (September 2014)
Volume 19, Issue 8, Pages (August 2012)
Volume 21, Issue 10, Pages (October 2014)
Volume 18, Issue 11, Pages (November 2011)
Binding Specificity of Retinal Analogs to Photoactivated Visual Pigments Suggest Mechanism for Fine-Tuning GPCR-Ligand Interactions  Sundaramoorthy Srinivasan,
Volume 21, Issue 9, Pages (September 2014)
Volume 15, Issue 11, Pages (November 2008)
Volume 19, Issue 6, Pages (June 2012)
James H. Cormier, Taku Tamura, Johan C. Sunryd, Daniel N. Hebert 
Presentation transcript:

Volume 12, Issue 2, Pages 237-247 (February 2005) A Neoceptor Approach to Unraveling Microscopic Interactions between the Human A2A Adenosine Receptor and Its Agonists  Kenneth A. Jacobson, Michihiro Ohno, Heng T. Duong, Soo-Kyung Kim, Susanna Tchilibon, Michal Cˇesnek, Antonín Holý, Zhan-Guo Gao  Chemistry & Biology  Volume 12, Issue 2, Pages 237-247 (February 2005) DOI: 10.1016/j.chembiol.2004.12.010 Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 1 Structures of Nonselective Adenosine Receptor Ligands (3, 4) and Several Amine Derivatives (1, 2) Previously Studied at A2AAR Neoceptors Chemistry & Biology 2005 12, 237-247DOI: (10.1016/j.chembiol.2004.12.010) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 2 Synthesis of N6-Derivatized Adenosine Analogs 5 and 6 Reagents: (A) (i) ethylendiamine, rt., 24 hr; (ii) 1 N HCl, MeOH-H2O (1:1), 55°C, 36 hr, 65%. (B). (i) 2,2-dimethoxypropane, p-TsOH, acetone, 4 hr, 85%; (ii) TBDMS-Cl, imidazole, pyridine, 1 hr, 83%; (iii) guanidine solution, DABCO, 3 hr, 70%; (iv) Bu4N+F-, THF, 1hr, 95%; (v) KMnO4, KOH, H2O, 5 hr, 50%; (vi) H2SO4, 3 hr, 60°C, 84%; (vii) (a) ClCOOEt, N,N- i-Pr2NEt, DMF, 0°C; (b) EtNH2 in MeOH, 0°C 1 hr, RT 24 hr, 50%. Chemistry & Biology 2005 12, 237-247DOI: (10.1016/j.chembiol.2004.12.010) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 3 Synthetic Routes to Various Mono- and Disubstituted Adenosine-5′-Uronamide Derivatives (A) Synthesis of adenosine-5′-uronamide analogs 1 and 8–10. (B) Synthesis of N6-(2-methylbenzyl)adenosine-5′-uronamide analogs 12–15. Reagents: (i) CrO3, AcOH, 18%; (ii) TMSCHN2, MeOH, 88%; (iii) RNH2, DMF, 60°C; (iv) 1N HCl MeOH-H2O (1:1) 55°C, 2 d; (v) RP-SiO2 C18, for 7, Amberlite CG-50, for 11 and 12–15; (vi) Boc-NH(CH2)nNH2, iPr2NEt, DMF, 60°C, 54%–97%; (vii) Amberlite CG-50, 13%–67%; (viii) 2-MeBnBr; (ix) ethylamine or ethanolamine, MeOH, heat, Dimroth rearrangement and aminolysis of ester. Chemistry & Biology 2005 12, 237-247DOI: (10.1016/j.chembiol.2004.12.010) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 4 Pharmacological Characterization of Two Neoagonists Indicates Selective Interaction with Neoceptors Derived from the A2AAR Binding (A and B) and functional (C and D) effects of two adenosine derivatives, the hydrazide derivative 7 (A) and the N6-(2-methylbenzyl)-5′-aminoethyluronamide derivative 14 (B) at WT (■) and mutant A2AARs (T88D [▴], N181D [♦], and Q89D [▾]) transiently expressed in COS-7 cells. In the binding experiments, cell membranes (10–20 μg protein) were incubated with the radiolabeled antagonist [3H]ZM241385 (2.0 nM) in duplicate, together with increasing concentrations of the competing nucleoside, in a final volume of 0.4 ml Tris-HCl buffer (50 mM, pH 7.4) at 25°C for 120 min. Results were from a representative experiment performed in duplicate. The Ki values listed in Table 1 were from at least three separate experiments. In the functional experiments, cells expressing WT or mutant receptors were then treated with agonist 7 (C) or 14 (D) in the presence of rolipram (10 μM) and adenosine deaminase (3 units/ml) and incubated at 37°C for 1 hr. cAMP accumulation was determined using a competitive protein binding method [29]. The EC50 values (n = 3) determined for stimulation of cAMP formation were (nM, mean ± SEM): WT, 826 ± 138; T88D, 2970 ± 980; Q89D, 5.1 ± 0.8; N181D, 120 ± 22 for 7; and WT, 5800 ± 1230; T88D, 12,600 ± 3200; Q89D, 58 ± 12; N181D, 52 ± 6 for 14. Chemistry & Biology 2005 12, 237-247DOI: (10.1016/j.chembiol.2004.12.010) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 5 Proposed Modes of Docking of Two Neoagonists in Rhodopsin-Based Homology Models of Neoceptors Derived from the A2AAR The binding site of (A) the N181D-A2AAR/1 and (B) the Q89D-A2AAR/7 complex. All ligands are displayed as ball-and-stick models in the atom-by-atom color, and the side chains of human A2AAR are shown as stick models. The H bonding between ligand and the mutant receptor is displayed in yellow. The A2AAR is represented by a tube model with a different color for each TM domain (TM3 in yellow, TM5 in green, TM6 in cyan, and TM7 in purple). Chemistry & Biology 2005 12, 237-247DOI: (10.1016/j.chembiol.2004.12.010) Copyright © 2005 Elsevier Ltd Terms and Conditions